Accounts Receivable, after Allowance for Credit Loss, Current of CorMedix Inc. from 31 Dec 2012 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
CorMedix Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD history and change rate from 31 Dec 2012 to 31 Dec 2025.
  • CorMedix Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 31 Dec 2025 was $171,233,000.
Source SEC data
View on sec.gov
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)

CorMedix Inc. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $171,233,000* +$119,579,000 31 Dec 2025 10-K 05 Mar 2026 2025 FY
Q3 2025 $158,574,116* +$141,186,670 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $42,911,634 +$42,705,297 +20697% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $54,611,147 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $51,654,000 31 Dec 2024 10-K 05 Mar 2026 2025 FY
Q3 2024 $17,387,446 30 Sep 2024 10-Q 30 Oct 2024 2024 Q3
Q2 2024 $206,337 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q4 2018 $10,904 -$53,244 -83% 31 Dec 2018 10-K 29 May 2019 2018 FY
Q4 2017 $64,148 +$52,134 +434% 31 Dec 2017 10-K 29 May 2019 2018 FY
Q4 2016 $12,014 -$303,757 -96% 31 Dec 2016 10-K 19 Mar 2018 2017 FY
Q4 2015 $315,771 +$235,588 +294% 31 Dec 2015 10-K 16 Mar 2017 2016 FY
Q4 2014 $80,183 +$77,844 +3328% 31 Dec 2014 10-K 15 Mar 2016 2015 FY
Q4 2013 $2,339 +$2,339 31 Dec 2013 10-K 12 Mar 2015 2014 FY
Q4 2012 $0 31 Dec 2012 10-K 31 Mar 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.